MuSK Myasthenia 1000 Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age7-99
SponsorGeorge Washington University
About this trial
The MuSK myasthenia gravis 1000 study seeks to collect saliva samples from 1000 subjects with laboratory confirmed diagnosis of MuSK myasthenia to identify genetic variations associated with MuSK MG. The data collected may be used by researchers to gain a better understanding of the cause of MuSK MG and to identify biomarkers and targeted therapy for MuSK MG.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Lab test confirming diagnosis of MuSK myasthenia gravis
Willingness to provide saliva sample via mail or in person
Disqualifiers
Inability to provide informed consent
Unwillingness to provide lab results of elevated muscle specific kinase antibody
Unwillingness to provide saliva sample
Trial population
musk myasthenia gravis patients
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
GWAS
identify genetic characteristics associated with musk myasthenia gravis
Time frame
2 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov